Navigation Links
Chemo May Boost Survival After Lung Cancer Surgery
Date:3/24/2010

Therapy improves outcome for some patients with operable disease, review finds

WEDNESDAY, March 24 (HealthDay News) -- Chemotherapy improves survival for patients with operable non-small cell lung cancer, say researchers who reviewed nearly 50 studies.

The first meta-analysis of 34 studies involving almost 8,500 patients (and more than 3,300 deaths) showed that survival at five years was 64 percent for patients who had chemotherapy and surgery, and 60 percent for patients who had surgery alone.

The second meta-analysis of 13 studies with 2,660 patients (1,909 deaths) showed that survival at five years was 33 percent for patients who had surgery plus radiotherapy and chemotherapy, and 29 percent for patients who had surgery plus radiotherapy alone.

The report was released online March 23 in advance of publication in an upcoming print issue of The Lancet.

"In both meta-analyses we noted little variation in effect according to the type of chemotherapy, other trial characteristics, or patient subgroup," wrote the British and French researchers.

According to a team led by Sarah Burdett of the Medical Research Council Clinical Trials Unit, London, adding in chemotherapy boosted outcomes whether or not patients got the treatment alongside surgery alone, or surgery plus radiotherapy. They contend that, in patients deemed suitable, "platinum-based chemotherapy should be considered for patients at high risk of recurrence -- i.e., those with stage 1B, 2 or 3 disease."

The finding supports the use of chemotherapy in patients with non-small cell lung cancer who have also undergone tumor-removing surgery, Dr. Gregory P. Kalemkerian, of the University of Michigan, wrote in an accompanying commentary.

"Although the survival benefit seems small, worldwide adoption of adjuvant chemotherapy could save up to 10,000 lives every year," he said.

More information

The U.S. National Cancer Institute has more about non-small cell lung cancer.



-- Robert Preidt



SOURCE: The Lancet, news release, March 23, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Recommended Dental Care for Chemotherapy Patients -- Advice from Steven McConnell, DDS
2. Chemotherapy plus synthetic compound provides potent anti-tumor effect in pancreatic cancers
3. Researchers find new chemotherapy combination shows promise in endometrial cancer
4. BioSphere Medical's HepaSphere Microspheres Safely Deliver Doxorubicin in Liver Cancer Chemoembolization Therapy -- Study Presented at SIR
5. Are New Chemo Treatments Cost-Effective?
6. Older Colon Cancer Patients Less Likely to Get Chemo
7. Study evaluates costs and benefits of new chemotherapy drugs
8. Scientists identify microRNA as possible cause of chemotherapy resistance
9. Roche/Genentech/Chugais Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer
10. New developments in nanotechnology tackle the 2 biggest problems associated with chemotherapy
11. Patients with resectable esophageal adenocarcinoma benefit from neoadjuvant chemoradiotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2017)... ... ... Millennium”: a gripping take on how the author used personal experience to strengthen the ... do not affect daily choices. It shows how to act like the heirs of ... chosen. “How to Live in the Millennium” is the creation of published author, Gina ...
(Date:9/26/2017)... ... September 26, 2017 , ... “Sonflower Submission”: a ... nature to the inevitable destinations of negativity, complaining and the need to always be ... take effect in order for a lesson in stress-less living to be learned. ...
(Date:9/25/2017)... ... September 26, 2017 , ... Your World Insurance Services, a long-time ... began fulfilling a life-long wish of owner Stacy Boyle to give back to the ... help when I was in high school,” said Ms. Boyle. “My father passed away ...
(Date:9/25/2017)... ... September 25, 2017 , ... SyncDog, ... release of SentinelSecure™, version 3.0, will be available in a managed cloud services ... of SentinelSecure™ comes with several new enhancements including support for caller ID and ...
(Date:9/25/2017)... ... September 25, 2017 , ... The Byron Eaton Agency, a Birmingham based ... region, is organizing a local charity drive to send money and support to families ... of water have fallen on Houston as a result of Hurricane Harvey, raising water ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... BioLife Solutions , Inc. (NASDAQ: BLFS ), the ... and tissue hypothermic storage and cryopreservation freeze ... and CEO, will be presenting at two investment conferences in ... th Annual Global Investment Conference on Tuesday, September 12th, ... conference is being held at the New York Palace Hotel ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly and ... will present new data for galcanezumab and lasmiditan, two ... the International Headache Society (IHC) taking place Sept. 7-10 ... Lilly will highlight new, long-term data from an open-label ... of galcanezumab (120 mg and 240 mg) for the ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... a clinical-stage pharmaceutical company focused on the development of ... successfully concluded its meeting with the U.S. Food and ... insulin formulation. At ... regulatory pathway for submission of ORMD-0801, would be a ...
Breaking Medicine Technology: